Nadilka Hettiarachchige

Nadilka Hettiarachchige currently serves as the Global Director of Medical Affairs at Ascelia Pharma AB since April 2022. Previously, Nadilka held various roles at Novo Nordisk from May 2017 to April 2022, including Global Commercial Alzheimer Disease (STA) and Diabetes Medical Director for the North West Europe region, where responsibilities included co-chairing the Diabetes Medical Affairs Leadership Team and driving strategic direction and initiatives in medical affairs. Additional experience includes positions at AstraZeneca as a Senior Medical Advisor in Diabetes, and roles at Novartis, Bristol Myers Squibb, and Menarini, focusing on medical advice and support for product marketing. Nadilka's educational background includes an MD from Università degli Studi di Napoli Federico II and a Master's in Healthcare and Pharma Marketing from SDA Bocconi.